Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023161781> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2023161781 endingPage "1914" @default.
- W2023161781 startingPage "1908" @default.
- W2023161781 abstract "Four dosing regimens of 2',3'-dideoxycytidine (ddC) were administered intravenously for 10 to 28 days to 18 pigtailed macaques with simian acquired immunodeficiency syndrome. Ten macaques naturally infected with simian acquired immunodeficiency syndrome retrovirus serotype 2 (SRV-2), the etiologic agent of simian acquired immunodeficiency syndrome, received ddC by continuous intravenous infusion or by a daily bolus injection for 10 to 12 days. Another eight macaques that were negative for SRV-2 and antibody received ddC prophylaxis prior to challenge with virus and continued to receive ddC therapy for up to 28 days postchallenge. All monkeys treated with a continuous intravenous dose of ddC, which maintained plasma concentrations of ddC at levels known to inhibit SRV-2 in vitro, developed dose-related toxic effects, including leukopenia, anemia, lethargy, and decreased appetite. Monkeys treated with a daily bolus injection of ddC experienced more severe toxic effects than those on the continuous intravenous regimen, including exfoliative dermatitis and peripheral neuropathy. At the concentrations of ddC administered, no significant inhibition of SRV-2 replication was detected in naturally infected macaques. However, a prophylactic regimen of ddC did have an inhibitory effect on SRV-2. Our findings suggest that ddC may be valuable as a short-term prophylactic treatment rather than as a long-term therapy." @default.
- W2023161781 created "2016-06-24" @default.
- W2023161781 creator A5043361423 @default.
- W2023161781 creator A5053194586 @default.
- W2023161781 creator A5078084878 @default.
- W2023161781 creator A5082779370 @default.
- W2023161781 date "1989-11-01" @default.
- W2023161781 modified "2023-09-26" @default.
- W2023161781 title "Toxicity and efficacy of 2',3'-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2" @default.
- W2023161781 cites W1676930305 @default.
- W2023161781 cites W1977025244 @default.
- W2023161781 cites W1986089006 @default.
- W2023161781 cites W1987275257 @default.
- W2023161781 cites W2007913357 @default.
- W2023161781 cites W2019833996 @default.
- W2023161781 cites W2074737967 @default.
- W2023161781 cites W2075517136 @default.
- W2023161781 cites W2089503779 @default.
- W2023161781 cites W2109457685 @default.
- W2023161781 cites W2333399282 @default.
- W2023161781 cites W2336515255 @default.
- W2023161781 cites W4256221661 @default.
- W2023161781 cites W51538217 @default.
- W2023161781 doi "https://doi.org/10.1128/aac.33.11.1908" @default.
- W2023161781 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/172786" @default.
- W2023161781 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2558613" @default.
- W2023161781 hasPublicationYear "1989" @default.
- W2023161781 type Work @default.
- W2023161781 sameAs 2023161781 @default.
- W2023161781 citedByCount "19" @default.
- W2023161781 countsByYear W20231617812013 @default.
- W2023161781 countsByYear W20231617812015 @default.
- W2023161781 crossrefType "journal-article" @default.
- W2023161781 hasAuthorship W2023161781A5043361423 @default.
- W2023161781 hasAuthorship W2023161781A5053194586 @default.
- W2023161781 hasAuthorship W2023161781A5078084878 @default.
- W2023161781 hasAuthorship W2023161781A5082779370 @default.
- W2023161781 hasBestOaLocation W20231617812 @default.
- W2023161781 hasConcept C126322002 @default.
- W2023161781 hasConcept C159047783 @default.
- W2023161781 hasConcept C203014093 @default.
- W2023161781 hasConcept C2522874641 @default.
- W2023161781 hasConcept C2777288759 @default.
- W2023161781 hasConcept C2777995582 @default.
- W2023161781 hasConcept C2780216070 @default.
- W2023161781 hasConcept C2780727368 @default.
- W2023161781 hasConcept C2780866839 @default.
- W2023161781 hasConcept C2780873365 @default.
- W2023161781 hasConcept C2781413609 @default.
- W2023161781 hasConcept C29730261 @default.
- W2023161781 hasConcept C71924100 @default.
- W2023161781 hasConcept C98274493 @default.
- W2023161781 hasConceptScore W2023161781C126322002 @default.
- W2023161781 hasConceptScore W2023161781C159047783 @default.
- W2023161781 hasConceptScore W2023161781C203014093 @default.
- W2023161781 hasConceptScore W2023161781C2522874641 @default.
- W2023161781 hasConceptScore W2023161781C2777288759 @default.
- W2023161781 hasConceptScore W2023161781C2777995582 @default.
- W2023161781 hasConceptScore W2023161781C2780216070 @default.
- W2023161781 hasConceptScore W2023161781C2780727368 @default.
- W2023161781 hasConceptScore W2023161781C2780866839 @default.
- W2023161781 hasConceptScore W2023161781C2780873365 @default.
- W2023161781 hasConceptScore W2023161781C2781413609 @default.
- W2023161781 hasConceptScore W2023161781C29730261 @default.
- W2023161781 hasConceptScore W2023161781C71924100 @default.
- W2023161781 hasConceptScore W2023161781C98274493 @default.
- W2023161781 hasIssue "11" @default.
- W2023161781 hasLocation W20231617811 @default.
- W2023161781 hasLocation W20231617812 @default.
- W2023161781 hasLocation W20231617813 @default.
- W2023161781 hasOpenAccess W2023161781 @default.
- W2023161781 hasPrimaryLocation W20231617811 @default.
- W2023161781 hasRelatedWork W2062650038 @default.
- W2023161781 hasRelatedWork W2129167564 @default.
- W2023161781 hasRelatedWork W2133565296 @default.
- W2023161781 hasRelatedWork W2163056912 @default.
- W2023161781 hasRelatedWork W2327602189 @default.
- W2023161781 hasRelatedWork W2388348438 @default.
- W2023161781 hasRelatedWork W2414243814 @default.
- W2023161781 hasRelatedWork W3011968788 @default.
- W2023161781 hasRelatedWork W4236979089 @default.
- W2023161781 hasRelatedWork W4239399291 @default.
- W2023161781 hasVolume "33" @default.
- W2023161781 isParatext "false" @default.
- W2023161781 isRetracted "false" @default.
- W2023161781 magId "2023161781" @default.
- W2023161781 workType "article" @default.